Del Monte Pacific (D03) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
21 Oct, 2026Executive summary
Continuing-operations turnover rose 12.9% year-over-year to US$203.7M, driven by growth in the Philippines and international markets.
Net profit attributable to owners increased to US$5.5M from US$0.4M in the prior-year quarter.
U.S. operations were deconsolidated effective 1 May 2025; Q1 results exclude the business.
Financial highlights
Gross profit increased 32.8% to US$66.1M; gross margin expanded to 32.5% from 27.6%.
EBITDA rose 10.7% to US$37.3M; operating profit increased 38.5% to US$35.9M.
Net debt from continuing operations decreased 5.4% to US$1,020.8M.
Operating cash flow rose 76.6% to US$76.8M from US$43.5M.
Capital expenditure increased 61.9% to US$43.4M.
Outlook and guidance
FY2026 profitability is expected, barring unforeseen circumstances.
Priorities include expanding Philippine consumer reach and channels, maintaining North Asian fresh pineapple leadership, and improving C74 pineapple productivity by over 15% year-over-year.
Product launches, productivity gains, proactive cost control, waste reduction and lower inventory write-offs remain priorities.
Latest events from Del Monte Pacific
- Net profit surged 192.6% on 9% higher sales, with restructuring underway to address negative equity.D03
Q1 2027 - Strong FY2026 growth and profitability, but negative equity restricts dividends.D03
Q4 2026 - Strong sales and margin gains offset U.S. exit, but negative equity and capital deficit persist.D03
Q3 2026 - Q2 sales rose 9.9% and net profit more than sevenfold, led by Asian markets and fresh exports.D03
Q2 2026 - Asian operations returned to profit after U.S. deconsolidation and impairment.D03
Q4 2025 - Sales up 4% but net loss widened to US$56m on higher costs and U.S. subsidiary challenges.D03
Q2 2025 - Sales up 4% year-over-year; net loss widened on US costs, but margin and turnaround efforts continue.D03
Q1 2025 - Net loss widened to $127m on flat sales; margin recovery and asset sales targeted in FY25.D03
Q4 2024 - Sales rose, but DMFC losses outweighed DMPI growth and widened the group loss.D03
Q3 2025